Short News


short news

SAFES to hold its next conference
in Sri Lanka in 2019

LAHORE: Dr. Abbas Raza, President of South Asian Federation of Endocrine Societies (SAFES) speaking in the inaugural session of SAFES conference just concluded at Lahore announced that the next SAFES conference will be hosted by Sri Lanka in 2019.  The first SAFES conference, he said, was held in Nepal, Second was hosted by Bangladesh while the Third is being held in Pakistan.

We are delighted to welcome all the foreign delegates including those from the SAARC countries and I am delighted to announce that we have over fifty speakers in the conference who will be making presentations in various sessions, Dr. Abbas Raza stated. Holding the SAFES conference and being its President, he further stated, was an honour as well as a Challenge. We have exciting plans for the future. We have diabetes education programme, Fight against Obesity in which we intend to target the younger generation while Good Life Style will be a priority.

Earlier Prof.Ali Jawa welcomed the participants from all over Pakistan as well as the foreign delegates to the conference and hoped that they will enjoy their stay in Pakistan and sharing knowledge and experience with colleagues during the three days conference. Prof. A. K.Azad Khan from Bangladesh and Dr.Ali Lateef from Maldives also briefly spoke on the occasion. Dr.Dina from Nepal addressing the audience said that this event will motivate people to come to Nepal again. Prof. Noel from Sri Lanka remarked that Sri Lanka has a very cordial relations with Pakistan and this SAFES conference will further strengthen SAFES.

 A Memorable Evening
for SAFES delegates

LAHORE: South Asian Federation of Endocrine Societies (SAFES) and Organizer of 15th annual Conference of Pakistan Society of Endocrinology hosted a memorable dinner reception at the Hazoori Bagh adjacent to the Badshahi Mosque and Royal Forte in Lahore for the conference delegates.

The conference held at Lahore from November 23-26th 2017 had attracted a large number delegates from all over Pakistan besides delegates from Bangladesh, Nepal, Sri Lanka, Abu Dhabi, Europe , USA, Canada and many other countries.   Special lightings at the venue presented a spectacular environment where the performance of famous singer Rahat Fateh Ali Khan made it yet more memorable. He presented many of his popular songs, Ghazals and received tremendous applause from the audience.

Yet another significant and important highlight at the Gala Dinner was the presentation of Special Mementoes to some selected founder members’ of Pakistan Endocrine Society.  Some of those who were present received their mementoes others may be presented later. It may be mentioned here that there are fourteen founder members of PES.  These Mementoes were presented by Prof. A.H.Amar, Dr.Abbas Raza, Prof.Ali Jawa and Prof. Saeed Mahar. Keeping up the past traditions of Pakistan Endocrine Society of honouring its senior members in recognition of their services to promote the specialty of endocrinology in Pakistan, Prof.A.H.Amar was also presented the Life Time Achievement Award on this occasion. Dr. Naeem ul Haque was also recognized when he was called as Father of Endocrinology in Pakistan by the Moderator who was conducting this session.

Prize winners of Free Paper
session during PES conference

LAHORE:  Dr. Shan Elahi won the first prize during the free papers session at the SAFES and 15th annual Conference of Pakistan Endocrine Society held here recently. His topic was “Emergence of Hashimoto’s Thyroiditis associated Thyroid Swelling among female patients presenting with simple benign goiter in Lahore”. The second prize was won by Dr.  Jaida Manzoor and his presentation was on “Ambiguous genitalia: An overview of seven years’ experience at the children’s Hospital and Institute of Child Health Lahore Pakistan” while the third prize was won by Dr. M. Furqan Bari from Dow University of Health Sciences “. The panel of judges who evaluated the oral presentations included Dr. Fatema Jawad from JPMA Karachi, Prof. Akhtar Sherin from Kohat and Dr. Osama Ishtiaq from Islamabad.

Dr. Musarrat Riaz from Baqai Institute of Diabetes and Endocrinology also presented the findings of a three years project wherein they looked whether “Do we need universal screening for diagnosis of Gestational Diabetes Mellitus among pregnant women of Pakistan. Their recommendation was that there was no low risk group and all pregnant women in Pakistan should be screened for Gestational Diabetes. She also commended the publication of SAFES Recommending and Action Plan for Gestational Diabetes Mellitus (GDM) and congratulated the PES for this work besides appreciating the efforts of all those who were involved in this.

AKU to build Cardiac
Sciences Tower

KARACHI: Aga Khan University is planning to build a Cardiac Sciences Tower at its campus. This was disclosed by Mr. Jahannes Kedzierski Chief Executive Officer of Aga Khan University Hospital while speaking at the plenary session on the second day of the 20th National Health Research Symposium of AKU held from November 3-5, 2017.

The present hospital, he said, was built thirty five years ago and since then things have changed a lot. Now we need to have another hospital. This Cardiac Sciences Tower, he said, will combine academics with patient care and it will integrate cardiology, thoracic surgery, vascular surgery and pulmonary services including genetic approaches. This will enhance patient care.  As a hospital, we also need to put more money in stem cell research, he added.

DOCTORSCON 2018 at Lahore
 from February 2-4, 2018

LAHORE: DOCTORSCON 2018 being organized by Pakistan Academy of Family Physicians will be held at Lahore from February 2-4, 2018 from. Dr. Aftab Iqbal Sheikh, is the Chairman Organizing Committee while Dr. Tariq Javaid, conference Secretary. For details contact:  Conference Secretariat, 3-AQ, Faisal town, Lahore. Tel: +92-42-35236676 Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Web:

How the authors can avoid
predatory journals?

LONDON: The follow three are the good resources for the authors of scientific papers to avoid predatory journals:

  1. Think.Check.Submit is a campaign to help authors select the best journal for their work -
  2. Wiley have issued a simple infographic for authors -
  3. Yet another related resource:

Think. Check. Attend is a campaign to help researchers avoid low-quality conferences.

Authors are also advised to select a journal which they (or their colleagues) already read and which publishes research that they hink is good and reliable. Pippa Smart, UK.

Aspirin lowers the
risk of Liver Cancer

Researchers from Taiwan found that individuals with hepatitis B- a known risk factor for liver cancer- were less likely to develop liver cancer if they received daily aspirin therapy. Lead investigator Dr. Teng Yulee of the department of Gastroenterology at Teaching Veterans General Hospital in Taiwan and colleagues recently reported their findings at the liver meeting 2017, held by the American Association for the study of Liver Diseases in Washington D.C.

According to the Centers for Disease Control and Prevention (CDC) approximately 15-25 percent of those with Chronic Hepatitis go on to develop cirrhosis or cancer. There are anti-viral therapies that can help to reduce liver cancer risk but these do not fully eradicate the risk. They estimated that the liver cancer risk reduced by over a third.

Cholesterol-Lowering Drugs
may help patients with Cirrhosis

Statins used for the treatment of high cholesterol may have other beneficial effects, but there has been reluctance to prescribe them to patients with liver disease because of concerns that they may cause abnormal liver enzyme levels in the blood. In a new Alimentary Pharmacology & Therapeutics analysis of data from the Danish National Patient Registry, patients with cirrhosis of the liver due to alcohol had a 43% lower risk of dying prematurely than patients not on statins. The results add to previous studies indicating that statins might help patients with chronic liver disease, including cirrhosis.

Our finding supports the hypothesis that statins may ameliorate the course of cirrhosis and decrease the rate of fibrosis, said Dr. Ulrich Bang, lead author of the study. The results are promising and we are looking forward to seeing whether prospective trials can verify the finding.

 Study points to a growing trend in
opioid use over the Past Two Decades

The prevalence of prescription opioid use increased from 4.1% of US adults in 1999-2000 to 6.8% in 2013-2014, according to a recent Pharmacoepidemiology and Drug Safety study. This trend was driven by a sharp increase in long-term use which increased from 1.8% to 5.4%. Of all opioid users in 2013-2014, 79.4% were long-term users compared with 45.1% in 1999-2000. Long-term use was associated with poorer physical health, concurrent benzodiazepine use, and history of heroin use. The study included data from 47,356 adult participants of National Health and Nutrition Survey from 1999-2000 to 2013-2014.

The sharply increasing trend in long-term use of prescription opioids is somewhat concerning because there is little research on the possible benefits of this form of treatment—whereas, the evidence about the negative health effects of long-term use of these medications is growing, said Dr. Ramin Mojtabai, author of the study.

 Undiagnosed Spine Fractures
often cause Pain in Older Men

Fewer than a quarter of new vertebral fractures are clinically diagnosed, yet they often cause symptoms. In a study of older men in the general population now published in the Journal of Bone and Mineral Research, clinically undiagnosed vertebral fractures that were evident on x-rays were associated with higher likelihood of back pain and limited physical activity. The findings build on similar results previously reported in older women and point to the need for more effective strategies to detect and prevent vertebral fractures. Preventing these fractures may reduce back pain and related disability in older men, wrote the authors.

© Professional Medical Publications. All rights reserved.